$HZNP News Article - Horizon Therapeutics plc Announces FDA Approval of an Update to the Indication Language for TEPEZZA (teprotumumab-trbw) to Specify its Use in Thyroid Eye Disease (TED) Patients Regardless of Disease Activity or Duration
https://marketwirenews.com/news-releases/hori...86626.html